搜尋
Emergent BioSolutions Inc
EBS添加自選
8.130USD
+0.190+2.39%
收盤 05/18, 16:00（美東）報價延遲15分鐘
421.13M總市值
虧損本益比TTM
關於 Emergent BioSolutions Inc 公司
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Emergent BioSolutions Inc簡介
公司代碼EBS
公司名稱Emergent BioSolutions Inc
上市日期Nov 15, 2006
CEOPapa (Joseph C)
員工數量900
證券類型Ordinary Share
年結日Nov 15
公司地址300 Professional Dr
城市GAITHERSBURG
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編20879
電話12406313200
網址https://emergentbiosolutions.com/
公司代碼EBS
上市日期Nov 15, 2006
CEOPapa (Joseph C)
Emergent BioSolutions Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
114.67K
+22.10%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
89.36K
+28.36%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
79.44K
+31.90%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
59.03K
+16.71%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
收入明細
單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
地區USD
名稱
營收
佔比
Non-U.S Government
403.20M
54.27%
U.S.Government
36.70M
4.94%
業務
地區
業務USD
名稱
營收
佔比
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
其他
72.72%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
其他
72.72%
股東類型
持股股東
佔比
Investment Advisor
37.35%
Investment Advisor/Hedge Fund
31.07%
Hedge Fund
8.77%
Research Firm
3.93%
Individual Investor
3.86%
Pension Fund
1.01%
Bank and Trust
0.36%
Family Office
0.06%
Insurance Company
0.02%
其他
13.55%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
412
42.30M
81.98%
-3.37M
2025Q4
378
39.86M
83.14%
+128.30K
2025Q3
417
39.73M
84.87%
+2.04M
2025Q2
439
37.58M
87.40%
+1.14M
2025Q1
454
36.44M
84.55%
-9.64M
2024Q4
461
35.04M
82.31%
+2.84M
2024Q3
467
32.21M
81.37%
+1.29M
2024Q2
485
30.86M
99.60%
-5.54M
2024Q1
494
36.44M
103.37%
-17.72M
2023Q4
512
41.89M
103.68%
-1.06M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.92M
7.6%
+17.75K
+0.45%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.25M
4.36%
+112.27K
+5.25%
Dec 31, 2025
State Street Investment Management (US)
2.70M
5.22%
+250.62K
+10.25%
Dec 31, 2025
American Century Investment Management, Inc.
2.44M
4.72%
+57.06K
+2.40%
Dec 31, 2025
Charles Schwab Investment Management, Inc.
1.62M
3.13%
+237.15K
+17.16%
Dec 31, 2025
Palisade Capital Management, LLC
1.27M
2.45%
-160.25K
-11.24%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.25M
2.42%
-28.68K
-2.24%
Dec 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.16%
--
--
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AdvisorShares Insider Advantage ETF
0.97%
Royce Quant Small-Cap Quality Value ETF
0.41%
State Street SPDR S&P Biotech ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.23%
Harbor Human Capital Factor US Small Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Pacer US Small Cap Cash Cows ETF
0.16%
Invesco RAFI US 1500 Small-Mid ETF
0.15%
Avantis US Small Cap Value ETF
0.14%
iShares Micro-Cap ETF
0.13%
查看更多
AdvisorShares Insider Advantage ETF
佔比0.97%
Royce Quant Small-Cap Quality Value ETF
佔比0.41%
State Street SPDR S&P Biotech ETF
佔比0.28%
Federated Hermes MDT Small Cap Core ETF
佔比0.23%
Harbor Human Capital Factor US Small Cap ETF
佔比0.19%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.18%
Pacer US Small Cap Cash Cows ETF
佔比0.16%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.15%
Avantis US Small Cap Value ETF
佔比0.14%
iShares Micro-Cap ETF
佔比0.13%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
